Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
IRCT |
Last refreshed on:
|
11 September 2018 |
Main ID: |
IRCT2017022022965N6 |
Date of registration:
|
2017-09-03 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Comparing the effect of vitamin D weekly with daily in treatment of patients with vitamin D deficiency
|
Scientific title:
|
Comparing the effect of 50000 units vitamin D weekly with 7000 units daily in treatment of patients with vitamin D deficiency |
Date of first enrolment:
|
2017-08-23 |
Target sample size:
|
130 |
Recruitment status: |
Complete |
URL:
|
http://en.irct.ir/trial/19700 |
Study type:
|
interventional |
Study design:
|
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Patients assign into weekly treatment group or daily treatment group with simple randomization method, Randomization description: Simple randomization by sealed envelopes, Blinding description: This study was performed as a double-blind randomized clinical trial. Patients and researcher were blinded.
|
Phase:
|
4
|
|
Countries of recruitment
|
Iran (Islamic Republic of)
| | | | | | | |
Contacts
|
Name:
|
Maryam Mehrpooya
|
Address:
|
Hamedan University of Medical Sciences, Shahid Fahmide avenue, Hamedan
65178
Hamedan
Iran (Islamic Republic of) |
Telephone:
|
+98 81 3838 1675 |
Email:
|
m_mehrpooya2003@yahoo.com |
Affiliation:
|
Hamedan University of Medical Sciences |
|
Name:
|
Maryam Mehrpooya
|
Address:
|
Hamedan University of Medical Sciences, Shahid Fahmide avenue, Hamedan
65178
Hamedan
Iran (Islamic Republic of) |
Telephone:
|
+98 81 3838 1675 |
Email:
|
m_mehrpooya2003@yahoo.com |
Affiliation:
|
Hamedan University of Medical Sciences |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: patients aged 18 years old and more levels of 25 hydroxy vitamin D below 30 nmol per liter
Exclusion criteria: Patient treated with vitamin D supplements during the past 3 months pregnant women lactating women patients with cognitive and psychiatric disorders that are not able to attend and complete the study patients who cannot receive oral medication patients with hyper-calcaemia, hypo-calcaemia patients with hyper-phosphatemia And Hypo-Phosphatemia Patients with Advanced Liver Diseases Patients with Renal Disease Patients receiving drugs that affect serum levels of vitamin D (phenytoin, phenobarbital, carbamazepine, valproate, etc.)
Age minimum:
no limit
Age maximum:
no limit
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Vitamin D deficiency. Avitaminosis D
|
Intervention(s)
|
Intervention 1: intervention group: 7000 units of vitamin D once a day for 8 weeks. Intervention 2: intervention group: 50000 units of vitamin D once weekly for 8 weeks.
|
Primary Outcome(s)
|
Vitamin D deficiency. Timepoint: at baseline, at the end of study. Method of measurement: Blood sample.
|
Source(s) of Monetary Support
|
Hamedan University of Medical Sciences
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Ethics Committee of the Hamedan University of Medical Sciences
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|